Uroplasty and Vision-Sciences have agreed to merge in the first half of 2015. The new company, which will be called Cogentix Medical, will be based in Minnetonka, Minn., and focus on medical devices for urologic treatment and diagnosis. Rob Kill, president and CEO of Uroplasty, will continue his role in Cogentix.
Brett Reynolds has been appointed to succeed Mahedi Jiwani as chief financial officer at Uroplasty. Reynolds previously served as CFO for Synovis Life Technologies for nine years before he went on to lead the Minnesota site of Baxter Healthcare, which acquired Synovis for $325 million last year.
Richard Brajer has resigned as CEO of LipoScience after working with the diagnostics company for 10 years. Robert Greczyn, who is a member of the company's board, has taken over as CEO on an interim basis.
Altura Medical has obtained $6 million in an equity financing round aiming for $10 million. The San Clemente, Calif.-based startup is working on stent grafts that can be used to treat patients with aneurysms in the arterial vascular system.
IRhythm Technologies has pulled in $15.1 million in an equity offering and hopes to raise $1.9 million more in that round. The San Francisco startup is the maker of the Zio patch, which the company said can monitor cardiac rhythm for a maximum of two weeks.